• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/52

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

52 Cards in this Set

  • Front
  • Back

Skills Needed Provide Info

1. Access Available info( collect situational data0


2. Formulate an appropriate question


3. Systemic approach


4. Evaluate info critically (validity/ applicability)


5. Develop, organize and summarize response


6. Communicate clearly


Anticipate other info needs

What is a drug information specialist
A well trained clinicial who knows how to locate, evaluate and apply drug info obtained from appropriate resources

Tertiary or General Reference

These are textbooks or reference books which are compilations of information collected from studies, reviews and other texts

Secondary References

These are abstracting and indexing sources of drug info. They may give only a reference to the original journal article or they may abstract or interpret the original literature for you

Primary References

These include original journal artices

How to evaluate a Tertiary Reference

Does this author have appropriate experience to publish in this area?


Is the info likely to be timely based on the publication date?


Is the info supported by appropriate citations?


Does the resource contain relevant information?


Does the resource appear free from bias and blatant error?

Drug Facts and Comparisons

Monthly (loose-leaf), annual (bound0 and electronic formats


Includes prescription, otc, investigational and orphan drugs


Extensive drug monographs


Be aware of general class info


3000 comprehensive charts and tables for easy comparisons of products with similar formulations

Physical Desk Reference (PDR)

Annual (print) and electronic formats


Compilation of FDA approved product labeling for commonly prescribed prescription drugs


Does not include investigational info if off-label uses of medications


Color images of select drugs


Does not include all prescription drugs


Specialty editions for nonprescription drugs, herbal medications, nutritional supplements and ophthalmic medicines

Handbook for Nonprescription Drugs: An interactive Approach to Self-care

-Published by the APhA


-Text also available as an e-book


-Text is organized by body system


-focus on disease states for which self-care would be appropriate


-provides comparative efficacy information of OTC products

RED BOOK

-Information on prescription and OTC product availability and pricing


-Number of tables including sugar-free, lactose-free and alcohol-free preparations


-NDC (National Drug Code) numbers


-Available in Micromedex

Americal Hospital Formulary Service (AHFS)

-Print and electronic format


-Published by ASHP


-Extensive collection of drug monographs


-Comprehensive review prior to publication


-Drug arraigned by AHFS nummber


-General statements precede the monograph


-Thorougly references, however can only be accessed via electonic version



Martindale: The Complete Drug Reference

-Print and electronic versions


-International drug information over 43 countries and regions


-Includes info on: selected herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins and poisons


-Mutilingual pharmaceutical terms


-Foreign product proprietary product names


-Forenign manufactures and distributors


-Active ingredients


-summary of indications


-extensively referenced


-available in Micromedex

Index Nominum

-International Drug Directory


-Print and Electronic Versions


-Information of drugs available of 171 countries


Inforation included: Structure, Therapeutic class and proprietary names for single entity medications

Clinical Pharmacology

-Electronic


-OTC drugs, prescriptions, investigational, nutritional and herbal products


-Updated in real-time with late-breaking medical news


-Drug Monographs


-Abbreviated monographs for older drugs


-References for less well known or controversial topics


Drug Information Handbook

-Lexicomp


-Print and Electronic


-Useful quick reference but often information is not as detailed as other references


-Drug Monographs


Useful appendices: Drug interactions, toxicology info and P450 inducers and inhibitors

Different versions of Lexicomp

Lexi Drugs Handbook


Pediatric and Neonatal Dosage Handbook


Geriatric Dosage Handbook


Lexi-Tox


Lab Tests and Diagnostic Procedures


Lexi Patient Education


Pregnancy and Lactation, In-depth


Infectious Diseases Handbook

Epocrartes

Family of Electronic Resources


Mobile and online products


Drug Monographs


Drug Interaction Checker


Tablet Identification


Diseases (Epidemology, prognosis, and treatment)


Micromedex

Compilation of a number of excellent databases


Electronic Access, Smart phone app


Drug monographs


toxicology


Drug Identification


Foreign Drugs


Reproductive Risk

Drug Points System
USPDI Volume I
Available in Statref
Good source of General Inforamtion
Drug Monographs
Includes OTC Medication

Detailed Drug Information for the Consumer

USPDI II


Available in STATref


Detailed drug information written in lay language


Drug Monographs


Good patient teaching source

Handbook of Injectable Drugs (Trissel's)

Hardcopy and electronic; available in STATref


Monographs of parenteral medications


Tables include: Solution compatibility, addictive compatibility, drugs in syringe compatibility and drugs in y-site compatibility

King Guide to Parenteral Admixtures

Loose-leaf, bound and electronic versions


Monographs of over 500 drugs


Tables provide compatibility in 12 common fluids: drug in solution and drugs in solution with other drugs


Includes info on parenteral nutrition

Meyler's Side Effects of Drugs

Comprehensive source of adverse drug interactions


Drug monographs with detailed ADR data


Comprehensive references to primary literature


Reports of clinically relevant drug interactions

Side Effects of Drugs Annual

A worldwide yearly survey of new data and trends in adverse drug reactions


Companion text to Meyler's


Supplements Meyler's between editions


A team evaluates international published ADR literature and summarizing the information

Drug Interaction Facts

Hardcopy and Electronic


Drug-drug and drug-food interactions


Each interaction review contains: significance rating, onset, severity rating, documented effects, mechanism of interaction and management options

Hansten and Horn's Drug interaction Analysis and Management

Similar to Drug Interaction Facts


Risk factors


Mechanism of interaction


Related Drugs


References

Drugs in Pregnancy and Lactation

In the R2 Library


Compilation of 1200 common drugs


Summarize current literature of fetal risk and impact on breastfeeding


Includes references


Also review Lact-Med in the NLM

The Harriet Lane Handbook

Pediatric Reference


Common diseases and conditions in the newborn to adolescent patient


Concise medication dosing


Monographs are brief and do not have detailed information or references


Common Side Effects


Separate publication for antimicrobiial therapy

Pediatric and Neonatal Dosage Handbook

900 monographs for pediatric and neonatal dosing


Includes 100 extemperaneous preparation recipes


Comprehensive appendices: acute life support, toxicology and conversion tables

Natural Standard

Print and Electronic Formats


Evidence based information for herbal products as well as complementary and alternative medicines


Each Product is graded A-F reflecting the quality of scientific evidence


Monographs include patient handouts

Natural Medicine Comprehensive Database

Monographs covering herbal and other complimentary medicines


Each monograph is evidence based and fully referenced


Provides guidance for use based on available evidence for safety and efficacy


Online version has additional info

Using Tertiary References

-Consult tertiary resources first when answering a DI question or finding a medication


-Do not rely on general tertiary info resources to find specific, focused types of info


-Do not rely on info found in only one tertiary resource. Always verify it with another available source

Secondary References

-Used to locate clinical studies or other original research (primary lit) that are published in medical or health-related journals


-Abstracting services- includes a complete citation and provides a brief overveiw of the article


Indexing Services which include a complete citation

Cochrane Library

-Evidence based Medicine Resource


-Collection of 6 databases:Cochrane Database of Systemic Reviews, Database of Reviews of Effectiveness(DARE) and Cochrane Central Register of Controlled Trials


-Extensively Reviewed


-All reviews follow a systemic approach so there is consistency in the reviews


Medline & PubMed

Covers 5500 biomedical journals from 70 different countries


Utilizes a controlled search vocabulary (MeSH)

Iowa Drug Information System (IDIS)

-Indexes articles from over 200 medical and pharmaceutical journals


-Articles are only indexed of they are directly relevant to drug use in humans


-Controlled vocabulary for searching


-Also includes FDA approval packages

International Pharmaceutical Abstracts (IPA)

-Focuses on pharmacy and pharmacy practice articles


-IPA indexes 750 journals as well as stte and local pharmacy publications


-Topics covered: biopharmaceutics, pharmacoinetics, new drug delivery systems, pharmacist liability, legal, political, ethical issues, pharmacology, drug stability, and drug evaluations

Journal Watch

Newsletter


most helpful for monitoring new clinical trials


Abstracting service for recent information


covers topics geared toward general practice physicans

Google Scholar

Search scholarly literature at no charge


utilizes internet search engine style


Loses specificity and revelance of results due to a lack of a controlled vocabularly


Limitations include: lack of info about journals covered, ranks article relevance by various methods including citation counts therefore new articles may not appear relevant because they do not have citation counts vs. older articles

Key Points About Secondary References

Allow for efficient location of relevant primary literature


Must use proper terminology (controlled vocabulary) for each secondary resource


A thorough search for relevant primary literature should include multiple secondary sources due to variation in journal coverage among resources

Preclinical Trials

-Assessment of Primary safety and biologic activity


-Involves animal and in vitro studies


-average duration 3.5 years

Phase I Clinical Trials

-Determination of primary safety and tolerance including safe dosage range


-involves 20 to 100 normal healthy adulty volunteers


-Average duration 1 year

Phase II Clinical Trial

-First evaluation of drug efficacy, dose response and side effects in patients in which the drug is intended


-Administered to 100 to 500 fairly homogeneous patients.


-Average duration 2-5 years

Phase III Clinical Trial

-Verification of drug effectiveness and safety, especially in long term use


-Establishment of optimum dosage


-Administered to 1000-3000 volunteers, relatively heterogeneous patients.


-avg duration 2 -4 years

Phase IV Clinical Trials

-Also known as Postmarketing Surveillance


-Intended to obtain more info about the benefits and risks associated with the drug's use in the general population


-Performed either prior to or after the release of the drug to the market


-Duration: Indefinite

Peer Review

-Editors of most journals use a systematic process to determine which articles are finally published


-Most articles are selected from voluntarily submitted articles by authors


-The journals reputation is based on the process and the criteria which it uses to select articles for publication


-Peer review system: "assessment by experts of the material submitted for publication in scientific and technical periodicals"


-Peer review is needed to handle the large number of articles submitted for publication annually

Peer Review System

1. A journal editor sending manuscripts to one to three "experts" for review and comment on the research methodology and the clinical significance of the findings


2. Peer reviewers are anonymous to the articles authors and vice versa


3. Peer reviewers, accept, revise or reject a manuscript for publication


4. Journal editor examines the reviews and decides on publication of the article


5. Reputable journals usually reject approximately 60% of the articles submitted


Typical Structure of Articles Describing Clinical Drug Trials

Title: Brief description of the research conducted


Abstract: Overview of the research conducted


I


ntroduction: Background information for the trial including results of prior research



Methods: Description of drug research design, inclusion/exclusion criteria, number needed, dosing info, measures of efficacy and safety



Results and Data Analysis: Analysis of research findings, including discussion of dropouts, discontinuation of drug therapy.



Discussion and Conclusions: Interpretations of results, comparison to current standard drug treatment, discussion of future implications of research



References: Evidence that prior research has been considered in designing and interpreting the trials


Study Design Deficiencies

Overall Design


Biases: selection, intervention, measurement and withdrawal

Deficiences in Presentation

Data Omitted


Poorly Written


Self promotion


boring


ignores other important work

Deficiences of Interpretation

Data to preliminary



Conclusions Unsupported by data: statistically significant but clinically irrelevant, not generalizable



Biased intepretation



Ignores Economic Consequences


Questions of Importance of Research

Results unoriginal, predictable or trivial


issue outdated, no longer relevant


Results of narrow interest, highly specialized


Risk factors of marginal importance


few or no clinical implications